Skip to content

Lysergic acid diethylamide

LSD

50 registered trials on the federal registry, 5 of them in Phase 3, and 8 recruiting now.

50
Registered trials
8
Recruiting
5
In Phase 3
4
With results posted

Open now

8 recruiting LSD trials

Indications

What LSD is being tested for

Stay told

When a new LSD trial opens

Research alerts

Get a notification when a trial for LSD trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Everything

All 50 LSD trials

TrialStatusPhaseSites
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc.RecruitingPhase 330
LSD Treatment for Persons With Alcohol Use DisorderNCT05474989 · Felix MuellerRecruitingPhase 22
Lysergic Acid Diethylamide (LSD) in Palliative CareNCT05883540 · University Hospital, Basel, SwitzerlandRecruitingPhase 24
LSD to Improve Cluster Headache Impact TrialNCT05477459 · Radboud University Medical CenterRecruitingPhase 22
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster HeadacheNCT03781128 · University Hospital, Basel, SwitzerlandRecruitingPhase 21
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy ParticipantsNCT06899334 · University Hospital, Basel, SwitzerlandRecruitingPhase 11
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSDNCT07461532 · Northern Jiangsu People's HospitalRecruitingNot applicable1
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSDNCT07309471 · University Hospital, Basel, SwitzerlandRecruitingNot applicable1
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)NCT06809595 · Definium Therapeutics US, Inc.Active, not recruitingPhase 336
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844 · Definium Therapeutics US, Inc.Active, not recruitingPhase 322
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 · Definium Therapeutics US, Inc.Active, not recruitingPhase 334
Sodium Lactate and Brain Relaxation (LSD)NCT04488874 · Centre Hospitalier Universitaire de BesanconCompletedPhase 31
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept TrialNCT05200936 · Definium Therapeutics US, Inc.CompletedPhase 22
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064 · Definium Therapeutics US, Inc.CompletedPhase 222
LSD Therapy for Persons Suffering From Major DepressionNCT03866252 · University Hospital, Basel, SwitzerlandCompletedPhase 21
Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related AnxietyNCT00920387 · Multidisciplinary Association for Psychedelic StudiesCompletedPhase 21
The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship QualityNCT05670184 · Maastricht UniversityUnknown statusPhase 1 / Phase 21
LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety DisordersNCT03153579 · University Hospital, Basel, SwitzerlandCompletedPhase 22
Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) PatientsNCT00736307 · Royan InstituteCompletedPhase 1 / Phase 22
Shortened LSD Intervention for Major Depressive DisorderNCT07503002 · Johns Hopkins UniversityNot yet recruitingPhase 11
Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy SubjectsNCT05964647 · University Hospital, Basel, SwitzerlandCompletedPhase 11
Effects of LSD on Neuroplasticity in Healthy SubjectsNCT05177419 · University of FribourgCompletedPhase 11
Effects of SERT Inhibition on the Subjective Response to LSD in Healthy SubjectsNCT05175430 · University Hospital, Basel, SwitzerlandCompletedPhase 11
LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy SubjectsNCT04865653 · University Hospital, Basel, SwitzerlandCompletedPhase 11
Mood Effects of Serotonin AgonistsNCT03790358 · University of ChicagoCompletedPhase 12
Comparative Acute Effects of LSD, Psilocybin and MescalineNCT04227756 · University Hospital, Basel, SwitzerlandCompletedPhase 11
Mood Effects of Serotonin Agonists ExtendedNCT03934710 · University of ChicagoCompletedPhase 11
A Dose-Ranging Study of 50 µg to 100 µg LSD in Healthy VolunteersNCT05674669 · Eleusis TherapeuticsCompletedPhase 11
Effects of MDMA Co-administration on the Response to LSD in Healthy SubjectsNCT04516902 · University Hospital, Basel, SwitzerlandCompletedPhase 11
Effect of Ketanserin After LSD AdministrationNCT04558294 · University Hospital, Basel, SwitzerlandCompletedPhase 11
A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 YearsNCT04421105 · Eleusis TherapeuticsCompletedPhase 1
Mood Effects of Serotonin Agonists: DepressionNCT07017478 · University of ChicagoCompletedEarly Phase 11
Drug Effects on Mood and Behavior - ExpectancyNCT07061886 · University of ChicagoCompletedEarly Phase 11
LSD Occupancy of the Serotonin 2A Receptor in the Human BrainNCT05953038 · Rigshospitalet, DenmarkActive, not recruitingEarly Phase 11
Direct Comparison of Altered States of Consciousness Induced by LSD and PsilocybinNCT03604744 · University Hospital, Basel, SwitzerlandCompletedEarly Phase 11
Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)NCT03321136 · University Hospital, Basel, SwitzerlandCompletedEarly Phase 11
Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion ProcessingNCT03019822 · University Hospital, Basel, SwitzerlandCompletedEarly Phase 11
Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled StudyNCT01878942 · University Hospital, Basel, SwitzerlandCompletedEarly Phase 11
Neuronal Correlates of Altered States of ConsciousnessNCT02308969 · University Hospital, Basel, SwitzerlandCompletedEarly Phase 11
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic PsychedelicsNCT06624137 · Yale UniversityTerminatedN/A2
LSD-Perceptual-Choice-StudyNCT05976698 · University Hospital, Basel, SwitzerlandCompletedNot applicable1
Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and HypersplenismNCT07490405 · Northern Jiangsu People's HospitalNot yet recruitingN/A1
Effect of LSD on Renal Function in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)NCT07585786 · Northern Jiangsu People's HospitalNot yet recruitingN/A
Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)NCT07588334 · Northern Jiangsu People's HospitalNot yet recruitingN/A1
Acute Effects of Aerobic Exercise Intensity on Lower-Limb Muscle Strength and Power in Youth GymnastsNCT07415395 · Chaoran HanCompletedNot applicable1
Retrospective Observational Study of Intensity Effects in Psychedelic-assisted TreatmentNCT07164287 · University Hospital, GenevaActive, not recruitingN/A1
Microdosing LSD in Women With Premenstrual DisordersNCT07189299 · Friederike HolzeNot yet recruitingNot applicable1
Salivary Oxytocin as a Biomarker in Psychedelic Assisted PsychotherapyNCT06557239 · Tatiana Aboulafia BrakhaCompletedN/A1
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingNCT05570708 · Felix MuellerEnrolling by invitationNot applicable1
The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy VolunteersNCT02451072 · Psychiatric University Hospital, ZurichCompletedNot applicable1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. A trial counts for LSD only where the substance is named in its title, summary or interventions. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.